Maximum quantity allowed is 999
请选择数量
CAS RN: 58-39-9 | 產品號碼: P1970
產品規格
Appearance | White to Orange to Green powder to crystal |
Purity(HPLC) | min. 97.0 area% |
Purity(Nonaqueous Titration) | min. 97.0 % |
Melting point | 95.0 to 99.0 °C |
性質
熔點 | 97 °C |
水溶性 | Insoluble |
Degree of solubility in water | 28.3 mg/l 24 °C |
溶解性(可溶於) | Ethanol, Acetone |
GHS
圖形表示 |
![]() |
信號詞 | Warning |
危險性說明 | H302 : Harmful if swallowed. H413 : May cause long lasting harmful effects to aquatic life. |
防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
相關法規
RTECS # | TL7175000 |
運輸資料
HS編碼* | 2934.99-000 |
Application
Perphenazine: A Classical Phenothiazine Typical Antipsychotic
Perphenazine is a classical phenothiazine typical antipsychotic with a potency similar to haloperidol [H0912], a dopamine antagonist. It is extensively metabolized in the liver to a number of metabolites. The pharmacokinetics of perphenazine is mediated by cytochrome P450 2D6 (CYP2D6) and thus is subject to genetic polymorphism. It induces cleft palate in mice fetuses. (The product is for research purpose only.)
References
- Perphenazine (Trilafon) Metabolism in Psychotic Patients
- Steady-state serum concentrations of the neuroleptic perphenazine in relation to CYP2D6 genetic polymorphism
- Pharmacogenetics of classical and new antipsychotic drugs
- Reduction of Drug-Induced Cleft Palate in Mice
考研文獻
產品介紹報導
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。